These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 16720047)
1. Homogeneous PCR nucleobase quenching assays to detect four mutations that cause neuronal ceroid lipofuscinosis: T75P and R151X in CLN1, and IVS5-1G>C and R208X in CLN2. Leman AR; Polochock S; Mole SE; Pearce DA; Rothberg PG J Neurosci Methods; 2006 Oct; 157(1):124-31. PubMed ID: 16720047 [TBL] [Abstract][Full Text] [Related]
2. [From gene to disease; from CLN1, CLN2 and CLN3 to neuronal ceroid lipofuscinosis]. Taschner PE; Losekoot M; Breuning MH; Hofman I; van Diggelen OP Ned Tijdschr Geneeskd; 2005 Feb; 149(6):300-3. PubMed ID: 15730038 [TBL] [Abstract][Full Text] [Related]
9. An integrated strategy for the diagnosis of neuronal ceroid lipofuscinosis types 1 (CLN1) and 2 (CLN2) in eleven Latin American patients. Kohan R; Cismondi IA; Kremer RD; Muller VJ; Guelbert N; Anzolini VT; Fietz MJ; Ramírez AM; Halac IN Clin Genet; 2009 Oct; 76(4):372-82. PubMed ID: 19793312 [TBL] [Abstract][Full Text] [Related]
10. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Mole SE; Williams RE; Goebel HH Neurogenetics; 2005 Sep; 6(3):107-26. PubMed ID: 15965709 [TBL] [Abstract][Full Text] [Related]
11. The clinical and genetic epidemiology of neuronal ceroid lipofuscinosis in Newfoundland. Moore SJ; Buckley DJ; MacMillan A; Marshall HD; Steele L; Ray PN; Nawaz Z; Baskin B; Frecker M; Carr SM; Ives E; Parfrey PS Clin Genet; 2008 Sep; 74(3):213-22. PubMed ID: 18684116 [TBL] [Abstract][Full Text] [Related]
12. Neural and extraneural expression of the neuronal ceroid lipofuscinoses genes CLN1, CLN2, and CLN3: functional implications for CLN3. Chattopadhyay S; Pearce DA Mol Genet Metab; 2000; 71(1-2):207-11. PubMed ID: 11001812 [TBL] [Abstract][Full Text] [Related]
13. The neuronal ceroid-lipofuscinoses. Bennett MJ; Rakheja D Dev Disabil Res Rev; 2013; 17(3):254-9. PubMed ID: 23798013 [TBL] [Abstract][Full Text] [Related]
14. Late infantile neuronal ceroid lipofuscinosis: a new mutation in Arabs. Goldberg-Stern H; Halevi A; Marom D; Straussberg R; Mimouni-Bloch A Pediatr Neurol; 2009 Oct; 41(4):297-300. PubMed ID: 19748052 [TBL] [Abstract][Full Text] [Related]
15. Molecular diagnosis of and carrier screening for the neuronal ceroid lipofuscinoses. Zhong NA; Wisniewski KE; Ju W; Moroziewicz DN; Jurkiewicz A; McLendon L; Jenkins EC; Brown WT Genet Test; 2000; 4(3):243-8. PubMed ID: 11142754 [TBL] [Abstract][Full Text] [Related]
16. Overexpression in colorectal carcinoma of two lysosomal enzymes, CLN2 and CLN1, involved in neuronal ceroid lipofuscinosis. Tsukamoto T; Iida J; Dobashi Y; Furukawa T; Konishi F Cancer; 2006 Apr; 106(7):1489-97. PubMed ID: 16518810 [TBL] [Abstract][Full Text] [Related]
17. The molecular genetic basis of the neuronal ceroid lipofuscinoses. Gardiner RM Neurol Sci; 2000; 21(3 Suppl):S15-9. PubMed ID: 11073223 [TBL] [Abstract][Full Text] [Related]
18. The genetic spectrum of human neuronal ceroid-lipofuscinoses. Mole SE Brain Pathol; 2004 Jan; 14(1):70-6. PubMed ID: 14997939 [TBL] [Abstract][Full Text] [Related]
19. A novel CLN2/TPP1 mutation in a patient with late infantile neuronal ceroid lipofuscinosis. Yu F; Liu XM; Chen YH; Zhang SQ; Wang K Neurol Sci; 2015 Oct; 36(10):1917-9. PubMed ID: 26032578 [No Abstract] [Full Text] [Related]